Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Prenatal Folic acid...

    Prenatal Folic acid fortification prevents mental illness later: JAMA Study

    Written by Medha Baranwal Baranwal Published On 2018-07-05T19:25:55+05:30  |  Updated On 5 July 2018 7:25 PM IST
    Prenatal Folic acid fortification prevents mental illness later: JAMA Study



    A new study published in the JAMA Psychiatry shows that prenatal exposure to fortifying grain-based foods with folic acid is associated with alterations in cortical development, which in turn, reduces the incidence of psychosis and other mental illnesses in youths.




    The study, comparing brain images of school-aged youths born just prior to the fortification mandate to those of young people born afterward, found that increased in utero folic acid exposure was associated with changes in later brain development. These brain changes, in turn, predicted a reduced risk for symptoms of psychosis.


    Joshua Roffman, Department of Psychiatry, Massachusetts General Hospital, and colleagues conducted the study to evaluate associations among fetal folic acid exposure, cortical maturation, and psychiatric risk in youths.




    Fortifying grain-based foods with folic acid were instituted in the U.S. in the 1990s to prevent neural tube defects such as spina bifida, in which the spinal column does not completely close around the spinal cord, which can lead to severe disabilities in infants. Folate may play other important roles in the development of the fetal central nervous system, given its contributions to DNA and histone methylation, DNA synthesis, and gene expression.


    The hypothesis that prenatal exposure to folate may also influence postnatal brain development arises in part from epidemiologic studies that linked starvation during early fetal life with both neural tube defects and schizophrenia, and is further supported by studies that linked periconceptional folic acid supplements to lower risk of language delay and autism; however, 1 study failed to find such an association.


    "Severe mental illnesses such as autism and schizophrenia that strike children and young adults are devastating and chronic and, at present, have no known prevention or cure," says Dr. Roffman. "These illnesses are thought to start in the womb, so it makes sense to focus our efforts there. If even a fraction of these cases could be prevented through a benign and readily available intervention during pregnancy, it could be as transformative for psychiatry as vaccines have been for infectious disease or fluoridation for dentistry. Our results with folic acid take an important next step in that direction."





    Read Also: Folic Acid may lower Stroke Risk in Hypertensive patients

    The research team reviewed two sets of brain MR images taken when children and adolescents born from 1993 to 2001 were ages 8 to 18. One set consisted of normal brain images taken at the MGH as part of the clinical care of 292 patients; another set included images from 861 participants in the Philadelphia Neurodevelopmental Cohort, a study that included assessment of psychiatric symptoms, including those associated with psychotic disorders. Both of those groups were divided according to probable prenatal exposure to folic acid - those born before July 1, 1996, when fortification began, those born after July 1, 1998, when implementation was complete, and those born in the intervening two years, for whom group exposure would have been intermediate. The third set of images reflected 217 participants in a multi-site National Institutes Health (NIH) study, all ages 8 to 18 when imaged but born before folic acid fortification was instituted.


    Key Findings:

    • Images from both the MGH and Philadelphia cohorts revealed that young people born after full implementation of folic acid fortification had different patterns of cortical maturation compared with participants born before the program began.

    • These differences were characterized by significantly thicker brain tissue and delayed thinning of the cerebral cortex in regions associated with schizophrenia.

    • The cortical thickness of those born during the rollout period was intermediate between the two other groups. While a thinning of the cerebral cortex in school-aged children is a normal part of brain maturation - probably associated with processes like the elimination of unnecessary connections between neurons - previous studies have associated early and accelerated cortical thinning with autism and with symptoms of psychosis.

    • The delayed cortical thinning seen in fully folic-acid-exposed participants was associated with a significantly reduced risk of symptoms of psychosis.

    • Images from the NIH cohort, which was not exposed to folic acid fortification, found no evidence of the delayed cortical thinning seen in the folic-acid-exposed participants from the other two groups, supporting the association between prenatal folic acid exposure and delayed cortical thinning.




    "While our results link prenatal exposure to folic acid fortification with changes in cortical development and with a reduced risk of psychotic spectrum symptoms, they cannot directly link folic acid exposure to reduced schizophrenia risk, since the typical age of onset for that disorder is in the early 20s. But since such symptoms in youth are on the same continuum as schizophrenia, the results hold some promise for schizophrenia prevention." says Roffman. "The oldest participants in our study are now approaching the age of greatest risk for several psychiatric disorders - also including bipolar disorder and depression - so it will be of great interest to see whether exposure does have an effect on the incidence of these disorders. Future research should also look at how actual maternal folate levels relate to postnatal brain development and the risk of subsequent serious mental illness."


    "In replicated cohorts, fetal exposure to population-wide folic acid fortification was associated with subsequent alterations in cortical development among school-aged youths. In turn, these cortical changes were associated with reduced risk of psychosis. Our findings suggest that protective effects of prenatal folic acid exposure may extend beyond prevention of neural tube defects and span neurodevelopment during childhood and adolescence," concluded the authors.


    Read Also: Folic acid fortified food linked to decline in CDH : AHA Study

    For further information follow the link: 10.1001/jamapsychiatry.2018.1381

    brain developmentcortical developmentexposurefolic acidfortificationgestationalgrainJAMA PsychiatryJoshua RoffmanMental Illnessneural tube defectPregnancyprenatalpsychosispsychotic disordersschizophrenia
    Source : With inputs from JAMA Psychiatry

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok